Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2019 Q4
14 of 25 quarters
Total Value
$355.0K
Total Shares
20.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Miller Value Partners
$355.0K
20.0K
0.0%
Unchanged
Miller Value Partners
$355.0K
20.0K shares
Unchanged
HALO — Halozyme Therapeutics Inc - FilingSpy